(Q37743525)

22 August 2017

1 reference

title

Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection (English)

1 reference

22 August 2017

main subject

Clostridium difficile

0 references

author name string

Mark Miller

series ordinal

1

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

Expert Opinion on Pharmacotherapy

22 August 2017

published in

1 reference

22 August 2017

volume

11

1 reference

22 August 2017

issue

9

1 reference

22 August 2017

page(s)

1569-1578

1 reference

A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

An epidemic, toxin gene-variant strain of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Emergence of Clostridium difficile-associated disease in North America and Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Clostridium difficile PCR ribotype 078 toxinotype V found in diarrhoeal pigs identical to isolates from affected humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Relapse versus reinfection withClostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

The fascination with probiotics for Clostridium difficile infection: lack of evidence for prophylactic or therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Probiotics and diarrhea: Data are not widely applicable

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Treatment with monoclonal antibodies against Clostridium difficile toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Management of Clostridium difficile infection: survey of practices and compliance with national guidelines among primary care physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Emergence of reduced susceptibility to metronidazole in Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Mutation in the Bacillus subtilis RNA polymerase beta' subunit confers resistance to lipiarmycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

In vitro activities of OPT-80 and comparator drugs against intestinal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Activity of OPT-80, a novel macrocycle, compared with those of eight other agents against selected anaerobic species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

In vitro activity of OPT-80 against Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Safety, tolerance, and pharmacokinetic studies of OPT-80 in healthy volunteers following single and multiple oral doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Clinical outcomes, safety, and pharmacokinetics of OPT-80 in a phase 2 trial with patients with Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

OPT-80 eliminates Clostridium difficile and is sparing of bacteroides species during treatment of C. difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Nitazoxanide for the treatment of Clostridium difficile colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Health Care–AssociatedClostridium difficileInfection in Canada: Patient Age and Infecting Strain Type Are Highly Predictive of Severe Outcome and Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.485614

Structure and biological activity of lipiarmycin B

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.41.308

Tiacumicins, a novel complex of 18-membered macrolides. II. Isolation and structure determination

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.40.575

Tiacumicins, a novel complex of 18-membered macrolide antibiotics. I. Taxonomy, fermentation and antibacterial activity.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.40.567

Identifiers

DOI

10.1517/14656566.2010.485614

1 reference

22 August 2017

1 reference